Autostat II Anti-TPO
510(k) K943580
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK943580 | Date17 Apr 1995 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JNL
- FDA applicant
- Cogent Diagnotics , Ltd.
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5870
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
The Autostat II Anti-TPO is an immunochemical device used for the detection of thyroglobulin autoantibodies. It functions as an in vitro diagnostic tool within the field of immunology.
This device is manufactured by Cogent Diagnostics, Ltd. and has received FDA 510(k) clearance. It is classified as a Class II medical device under regulation number 866.5870.
Other devices from Cogent Diagnotics, Ltd.
Questions
AI-generated answers, 21 Sep 2026
What is the primary function of the Autostat II Anti-TPO?
The Autostat II Anti-TPO is an in vitro diagnostic tool designed specifically for the detection of thyroglobulin autoantibodies. It operates within the field of immunology to assist in clinical laboratory testing.
What is the regulatory classification of this device?
The Autostat II Anti-TPO is classified as a Class II medical device under regulation number 866.5870. It has received FDA 510(k) clearance, confirming it as substantially equivalent to other legally marketed devices.
Who is the manufacturer of the Autostat II Anti-TPO?
This device is manufactured by Cogent Diagnostics, Ltd., located in Edinburgh, United Kingdom. The company is the applicant responsible for the device's FDA 510(k) clearance under K943580.